Tapewire

Nasdaq · USD

UTHR

UNITED THERAPEUTICS Corp

Export transactions ↓
Tapewire entity
664
SEC CIK
0001082554
Parsed reports
1,261

Last 12 months

Inside the activity.

1 purchase rows · 2632 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 20250142
Dec 20250143
Jan 2026078
Feb 2026026
Mar 20260364
Apr 20260346
May 20261340
Jun 20260298
Jul 20260240
Aug 20260251
Sep 20260260
Oct 20260144

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 11, 2024 Filed Mar 13, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 1,269 $244.80 $310,646.25
Disclosure

SEC source: 0001415889-24-007814 · form4-03132024_040301.xml · nonDerivative · entry 2

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,861

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F2 · price: This transaction was executed in multiple trades at prices ranging from $244.365 to $245.22. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
Exercise / conversionCommon Stock 15,000 $129.49 $1,942,350.00
Disclosure

SEC source: 0001415889-24-007814 · form4-03132024_040301.xml · nonDerivative · entry 1

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,130

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

Read SEC document
March 08, 2024 Filed Mar 11, 2024 20:30 UTC Exercise / conversionShare Tracking Award · Derivative 9,791 $0.00 Strike: $123.75 $0.00
Disclosure

SEC source: 0001415889-24-007510 · form4-03112024_040304.xml · derivative · entry 3

Klein Katherine J · CIK 0001625073 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,584

Underlying: Common Stock · 9,791 shares

Expires 2024-11-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.

Read SEC document
March 08, 2024 Filed Mar 11, 2024 20:30 UTC Disposition to issuerCommon Stock 9,791 $243.05 $2,379,702.55
Disclosure

SEC source: 0001415889-24-007510 · form4-03112024_040304.xml · nonDerivative · entry 2

Klein Katherine J · CIK 0001625073 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,640

F1 · kind: Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.

Read SEC document
March 08, 2024 Filed Mar 11, 2024 20:30 UTC Exercise / conversionCommon Stock 9,791 $123.75 $1,211,636.25
Disclosure

SEC source: 0001415889-24-007510 · form4-03112024_040304.xml · nonDerivative · entry 1

Klein Katherine J · CIK 0001625073 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,431

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.

Read SEC document
March 08, 2024 Filed Mar 11, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
Exercise / conversionStock Options · Derivative 15,000 $0.00 Strike: $129.49 $0.00
Disclosure

SEC source: 0001415889-24-007513 · form4-03112024_040308.xml · derivative · entry 18

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 656,654

Underlying: Common Stock · 15,000 shares

Expires 2024-12-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

Read SEC document
March 08, 2024 Filed Mar 11, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 160 $243.89 $39,021.60
Disclosure

SEC source: 0001415889-24-007513 · form4-03112024_040308.xml · nonDerivative · entry 16

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 130

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F15 · price: This transaction was executed in multiple trades at prices ranging from $243.83 to $243.94. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 08, 2024 Filed Mar 11, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 5,139 $243.38 $1,250,719.54
Disclosure

SEC source: 0001415889-24-007513 · form4-03112024_040308.xml · nonDerivative · entry 15

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 290

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F14 · price: This transaction was executed in multiple trades at prices ranging from $242.80 to $243.75. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 08, 2024 Filed Mar 11, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 5,783 $242.23 $1,400,816.09
Disclosure

SEC source: 0001415889-24-007513 · form4-03112024_040308.xml · nonDerivative · entry 14

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,429

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F13 · price: This transaction was executed in multiple trades at prices ranging from $241.785 to $242.765. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 08, 2024 Filed Mar 11, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 895 $240.58 $215,319.10
Disclosure

SEC source: 0001415889-24-007513 · form4-03112024_040308.xml · nonDerivative · entry 13

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 11,212

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F12 · price: This transaction was executed in multiple trades at prices ranging from $240.315 to $241.04. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 08, 2024 Filed Mar 11, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 1,175 $239.56 $281,485.94
Disclosure

SEC source: 0001415889-24-007513 · form4-03112024_040308.xml · nonDerivative · entry 12

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 12,107

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F11 · price: This transaction was executed in multiple trades at prices ranging from $239.18 to $240.02. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 08, 2024 Filed Mar 11, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 1,225 $238.75 $292,465.20
Disclosure

SEC source: 0001415889-24-007513 · form4-03112024_040308.xml · nonDerivative · entry 11

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,282

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F10 · price: This transaction was executed in multiple trades at prices ranging from $238.14 to $239.03. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 08, 2024 Filed Mar 11, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 623 $237.21 $147,779.71
Disclosure

SEC source: 0001415889-24-007513 · form4-03112024_040308.xml · nonDerivative · entry 10

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 14,507

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F9 · price: This transaction was executed in multiple trades at prices ranging from $237.045 to $237.595. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 08, 2024 Filed Mar 11, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
Exercise / conversionCommon Stock 15,000 $129.49 $1,942,350.00
Disclosure

SEC source: 0001415889-24-007513 · form4-03112024_040308.xml · nonDerivative · entry 9

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,130

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

Read SEC document
March 08, 2024 Filed Mar 11, 2024 20:30 UTC Exercise / conversionShare Tracking Award · Derivative 2,000 $0.00 Strike: $88.03 $0.00
Disclosure

SEC source: 0001415889-24-007511 · form4-03112024_040306.xml · derivative · entry 5

Thompson Tommy G · CIK 0001324863 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 2,000 shares

Expires 2024-06-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.

Read SEC document
March 08, 2024 Filed Mar 11, 2024 20:30 UTC Disposition to issuerCommon Stock 2,000 $243.05 $486,100.00
Disclosure

SEC source: 0001415889-24-007511 · form4-03112024_040306.xml · nonDerivative · entry 2

Thompson Tommy G · CIK 0001324863 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,480

F1 · kind: Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.

Read SEC document
March 08, 2024 Filed Mar 11, 2024 20:30 UTC Exercise / conversionCommon Stock 2,000 $88.03 $176,060.00
Disclosure

SEC source: 0001415889-24-007511 · form4-03112024_040306.xml · nonDerivative · entry 1

Thompson Tommy G · CIK 0001324863 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,480

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.

Read SEC document
March 07, 2024 Filed Mar 7, 2024 21:52 UTC
MAHON PAUL AEVP & GENERAL COUNSEL
Exercise / conversionStock Options · Derivative 6,000 $0.00 Strike: $117.76 $0.00
Disclosure

SEC source: 0001415889-24-007191 · form4-03072024_090331.xml · derivative · entry 5

MAHON PAUL A · CIK 0001231589 · EVP & GENERAL COUNSEL

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 60,000

Underlying: Common Stock · 6,000 shares

Expires 2027-03-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on March 17, 2023.

Read SEC document
March 07, 2024 Filed Mar 7, 2024 21:52 UTC
MAHON PAUL AEVP & GENERAL COUNSEL
SaleCommon Stock 300 $238.85 $71,655.00
Disclosure

SEC source: 0001415889-24-007191 · form4-03072024_090331.xml · nonDerivative · entry 4

MAHON PAUL A · CIK 0001231589 · EVP & GENERAL COUNSEL

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 36,599

F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on March 17, 2023.

Read SEC document
March 07, 2024 Filed Mar 7, 2024 21:52 UTC
MAHON PAUL AEVP & GENERAL COUNSEL
SaleCommon Stock 2,700 $237.76 $641,949.57
Disclosure

SEC source: 0001415889-24-007191 · form4-03072024_090331.xml · nonDerivative · entry 3

MAHON PAUL A · CIK 0001231589 · EVP & GENERAL COUNSEL

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 36,899

F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on March 17, 2023.

F3 · price: This transaction was executed in multiple trades at prices ranging from $237.34 to $238.175. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 07, 2024 Filed Mar 7, 2024 21:52 UTC
MAHON PAUL AEVP & GENERAL COUNSEL
SaleCommon Stock 3,000 $236.90 $710,704.50
Disclosure

SEC source: 0001415889-24-007191 · form4-03072024_090331.xml · nonDerivative · entry 2

MAHON PAUL A · CIK 0001231589 · EVP & GENERAL COUNSEL

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 39,599

F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on March 17, 2023.

F2 · price: This transaction was executed in multiple trades at prices ranging from $236.34 to $237.31. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 07, 2024 Filed Mar 7, 2024 21:52 UTC
MAHON PAUL AEVP & GENERAL COUNSEL
Exercise / conversionCommon Stock 6,000 $117.76 $706,560.00
Disclosure

SEC source: 0001415889-24-007191 · form4-03072024_090331.xml · nonDerivative · entry 1

MAHON PAUL A · CIK 0001231589 · EVP & GENERAL COUNSEL

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 42,599

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on March 17, 2023.

Read SEC document
March 07, 2024 Filed Mar 11, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
Exercise / conversionStock Options · Derivative 15,000 $0.00 Strike: $129.49 $0.00
Disclosure

SEC source: 0001415889-24-007513 · form4-03112024_040308.xml · derivative · entry 17

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 671,654

Underlying: Common Stock · 15,000 shares

Expires 2024-12-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

Read SEC document
March 07, 2024 Filed Mar 11, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 95 $243.21 $23,104.92
Disclosure

SEC source: 0001415889-24-007513 · form4-03112024_040308.xml · nonDerivative · entry 8

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 130

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F8 · price: This transaction was executed in multiple trades at prices ranging from $243.00 to $243.23. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 07, 2024 Filed Mar 11, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 1,510 $242.25 $365,802.94
Disclosure

SEC source: 0001415889-24-007513 · form4-03112024_040308.xml · nonDerivative · entry 7

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 225

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F7 · price: This transaction was executed in multiple trades at prices ranging from $241.885 to $242.87. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 07, 2024 Filed Mar 11, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 4,478 $241.30 $1,080,548.56
Disclosure

SEC source: 0001415889-24-007513 · form4-03112024_040308.xml · nonDerivative · entry 6

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,735

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F6 · price: This transaction was executed in multiple trades at prices ranging from $240.88 to $241.83. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 07, 2024 Filed Mar 11, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 6,223 $240.29 $1,495,313.47
Disclosure

SEC source: 0001415889-24-007513 · form4-03112024_040308.xml · nonDerivative · entry 5

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 6,213

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F5 · price: This transaction was executed in multiple trades at prices ranging from $239.875 to $240.865. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 07, 2024 Filed Mar 11, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 478 $238.87 $114,177.47
Disclosure

SEC source: 0001415889-24-007513 · form4-03112024_040308.xml · nonDerivative · entry 4

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 12,436

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F4 · price: This transaction was executed in multiple trades at prices ranging from $238.605 to $239.28. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 07, 2024 Filed Mar 11, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 942 $237.77 $223,978.40
Disclosure

SEC source: 0001415889-24-007513 · form4-03112024_040308.xml · nonDerivative · entry 3

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 12,914

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F3 · price: This transaction was executed in multiple trades at prices ranging from $237.34 to $237.94. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 07, 2024 Filed Mar 11, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 1,274 $236.82 $301,707.66
Disclosure

SEC source: 0001415889-24-007513 · form4-03112024_040308.xml · nonDerivative · entry 2

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,856

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F2 · price: This transaction was executed in multiple trades at prices ranging from $236.34 to $237.11. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 07, 2024 Filed Mar 11, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
Exercise / conversionCommon Stock 15,000 $129.49 $1,942,350.00
Disclosure

SEC source: 0001415889-24-007513 · form4-03112024_040308.xml · nonDerivative · entry 1

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,130

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

Read SEC document
March 06, 2024 Filed Mar 7, 2024 21:30 UTC Exercise / conversionShare Tracking Award · Derivative 10,000 $0.00 Strike: $88.03 $0.00
Disclosure

SEC source: 0001415889-24-007187 · form4-03072024_040313.xml · derivative · entry 3

Giltner Richard · CIK 0001460472 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,000 shares

Expires 2024-06-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.

Read SEC document
March 06, 2024 Filed Mar 7, 2024 21:30 UTC Disposition to issuerCommon Stock 10,000 $236.97 $2,369,700.00
Disclosure

SEC source: 0001415889-24-007187 · form4-03072024_040313.xml · nonDerivative · entry 2

Giltner Richard · CIK 0001460472 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,620

F1 · kind: Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.

Read SEC document
March 06, 2024 Filed Mar 7, 2024 21:30 UTC Exercise / conversionCommon Stock 10,000 $88.03 $880,300.00
Disclosure

SEC source: 0001415889-24-007187 · form4-03072024_040313.xml · nonDerivative · entry 1

Giltner Richard · CIK 0001460472 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,620

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.

Read SEC document
March 06, 2024 Filed Mar 7, 2024 21:30 UTC Disposition to issuerShare Tracking Award · Derivative 2,000 $0.00 Strike: $88.03 $0.00
Disclosure

SEC source: 0001415889-24-007186 · form4-03072024_040303.xml · derivative · entry 5

Thompson Tommy G · CIK 0001324863 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,000

Underlying: Common Stock · 2,000 shares

Expires 2024-06-26

F1 · kind: Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.

Read SEC document
March 06, 2024 Filed Mar 7, 2024 21:30 UTC Disposition to issuerCommon Stock 2,000 $236.97 $473,940.00
Disclosure

SEC source: 0001415889-24-007186 · form4-03072024_040303.xml · nonDerivative · entry 2

Thompson Tommy G · CIK 0001324863 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,480

F1 · kind: Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.

Read SEC document
March 06, 2024 Filed Mar 7, 2024 21:30 UTC Exercise / conversionCommon Stock 2,000 $88.03 $176,060.00
Disclosure

SEC source: 0001415889-24-007186 · form4-03072024_040303.xml · nonDerivative · entry 1

Thompson Tommy G · CIK 0001324863 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,480

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.

Read SEC document
March 06, 2024 Filed Mar 7, 2024 21:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
Exercise / conversionStock Options · Derivative 15,000 $0.00 Strike: $129.49 $0.00
Disclosure

SEC source: 0001415889-24-007185 · form4-03072024_040301.xml · derivative · entry 16

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 686,654

Underlying: Common Stock · 15,000 shares

Expires 2024-12-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

Read SEC document
March 06, 2024 Filed Mar 7, 2024 21:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 957 $240.00 $229,683.54
Disclosure

SEC source: 0001415889-24-007185 · form4-03072024_040301.xml · nonDerivative · entry 14

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 130

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F13 · price: This transaction was executed in multiple trades at prices ranging from $239.57 to $240.53. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 06, 2024 Filed Mar 7, 2024 21:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 1,871 $239.05 $447,263.67
Disclosure

SEC source: 0001415889-24-007185 · form4-03072024_040301.xml · nonDerivative · entry 13

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,087

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F12 · price: This transaction was executed in multiple trades at prices ranging from $238.425 to $239.40. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 06, 2024 Filed Mar 7, 2024 21:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 1,348 $237.61 $320,300.57
Disclosure

SEC source: 0001415889-24-007185 · form4-03072024_040301.xml · nonDerivative · entry 12

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,958

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F11 · price: This transaction was executed in multiple trades at prices ranging from $237.33 to $238.06. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 06, 2024 Filed Mar 7, 2024 21:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 5,219 $236.77 $1,235,702.11
Disclosure

SEC source: 0001415889-24-007185 · form4-03072024_040301.xml · nonDerivative · entry 11

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,306

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F10 · price: This transaction was executed in multiple trades at prices ranging from $236.29 to $237.24. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 06, 2024 Filed Mar 7, 2024 21:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 1,284 $235.25 $302,062.54
Disclosure

SEC source: 0001415889-24-007185 · form4-03072024_040301.xml · nonDerivative · entry 10

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 9,525

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F9 · price: This transaction was executed in multiple trades at prices ranging from $235.12 to $236.00. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 06, 2024 Filed Mar 7, 2024 21:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 2,437 $234.57 $571,645.14
Disclosure

SEC source: 0001415889-24-007185 · form4-03072024_040301.xml · nonDerivative · entry 9

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 10,809

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F8 · price: This transaction was executed in multiple trades at prices ranging from $234.10 to $235.07. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 06, 2024 Filed Mar 7, 2024 21:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 559 $233.27 $130,395.86
Disclosure

SEC source: 0001415889-24-007185 · form4-03072024_040301.xml · nonDerivative · entry 8

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,246

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F7 · price: This transaction was executed in multiple trades at prices ranging from $232.88 to $233.795. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 06, 2024 Filed Mar 7, 2024 21:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 1,116 $231.73 $258,610.57
Disclosure

SEC source: 0001415889-24-007185 · form4-03072024_040301.xml · nonDerivative · entry 7

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,805

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F6 · price: This transaction was executed in multiple trades at prices ranging from $231.30 to $232.24. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 06, 2024 Filed Mar 7, 2024 21:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 209 $230.28 $48,129.04
Disclosure

SEC source: 0001415889-24-007185 · form4-03072024_040301.xml · nonDerivative · entry 6

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 14,921

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F5 · price: This transaction was executed in multiple trades at prices ranging from $230.00 to $230.93. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 06, 2024 Filed Mar 7, 2024 21:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
Exercise / conversionCommon Stock 15,000 $129.49 $1,942,350.00
Disclosure

SEC source: 0001415889-24-007185 · form4-03072024_040301.xml · nonDerivative · entry 5

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,130

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

Read SEC document
March 05, 2024 Filed Mar 7, 2024 21:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
Exercise / conversionStock Options · Derivative 6,300 $0.00 Strike: $129.49 $0.00
Disclosure

SEC source: 0001415889-24-007185 · form4-03072024_040301.xml · derivative · entry 15

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 701,654

Underlying: Common Stock · 6,300 shares

Expires 2024-12-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

Read SEC document
March 05, 2024 Filed Mar 7, 2024 21:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 453 $232.08 $105,130.56
Disclosure

SEC source: 0001415889-24-007185 · form4-03072024_040301.xml · nonDerivative · entry 4

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 130

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F4 · price: This transaction was executed in multiple trades at prices ranging from $232.02 to $232.125. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.